The government has now purchased a total of 500 million doses from Moderna, including 10 million doses for delivery in the fourth quarter of 2021 and 90 million doses for delivery in the first quarter of 2022. The drugmaker said that as of June 14, it has supplied 217 million released doses of the vaccine to the U.S.
The deal allows the U.S. to receive different versions of the vaccine, should such versions become necessary and cleared by the FDA.
“Importantly, the agreement gives the United States flexibility to choose which type of vaccine we will receive from Moderna if Moderna adjusts its formulation, for example, for pediatric vaccines or to address variants,” a White House official told The Hill.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
